Bruker Daltonics and the M2Aind Partnership for Innovation in Health Industry are organizing a two-day workshop on “MALDI Innovations in Pharma”, which shall take place on Feb 21st/22nd in Mannheim.
The first day will focus on rapifleX PharmaPulse – MALDI MS-based assays for compound profiling incl HTS. Day 2 will feature current applications in pharma industry and in chemical biology.

Please, register via the Bruker website:



No responses yet

Leave a Reply